Trademark Overview
On Tuesday, June 14, 2016, a trademark application was filed for CANCERNET with the United States Patent and Trademark Office. The USPTO has given the CANCERNET trademark a serial number of 87070319. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, April 12, 2017. This trademark is owned by Cellecta, Inc. The CANCERNET trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Assays for research purposes; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for scientific use; Diagnostic reagents for scientific or research use; Reagents for research purposes; Reagents for scientific or medical research use; Assays and reagents for use in genetic research; Diagnostic preparations for scientific or research use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology
Diagnostic biomarker reagents for medical purposes; Diagnostic reagents for medicinal use; Medical diagnostic reagents; Medical diagnostic reagents for the analysis of body fluids; Reagents for medical use; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, sepsis; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluids; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Reagents and media for medical and veterinary diagnostic purposes
Biological research; Biomedical research services; DNA analysis services for scientific research purposes; Laboratory research services relating to pharmaceuticals; Laboratory research in the field of genetics; Medical laboratory services; Medical research services in the field of cancer; Pharmaceutical research and development; Product research and development; Research and development of new products; Research on the subject of pharmaceuticals; Scientific laboratory services; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Research and development and consultation ...
Health care services, namely, providing a database in the field of cancer information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Medical diagnostic testing, monitoring and reporting services; Medical screening services in the field of cancer; Medical testing for diagnostic or treatment purposes; Genetic testing of animals for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of cancer; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals